GlyCosmos Portal

GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source	Last Updated
PSICQUIC	March 30, 2022

Displaying entries **1251 - 1275** of **4050** in total

« First

‹ Prev

…

47

48

49

50

51

52

53

54

55

…

Next ›

Last »
Antibody	Patient	Onset (days)	Symptom	GlyTouCan ID ▲	Arbitrary Fluorescence Units (AFU)
IgG	Patient 3	-180	mild	G25407RZ	49
IgM	Patient 3	-180	mild	G25407RZ	89
IgA	Patient 3	4	mild	G25407RZ	398
IgG	Patient 3	11	mild	G25407RZ	39
IgG	Patient 3	4	mild	G25407RZ	41
IgM	Patient 3	11	mild	G25407RZ	98
IgM	Patient 3	4	mild	G25407RZ	97
IgA	Patient 4	12	mild	G25407RZ	369
IgG	Patient 4	12	mild	G25407RZ	136
IgM	Patient 4	12	mild	G25407RZ	223
IgA	Patient 1	10	moderate	G25473LQ	415
IgA	Patient 1	22	moderate	G25473LQ	382
IgA	Patient 1	6	moderate	G25473LQ	332
IgG	Patient 1	10	moderate	G25473LQ	26
IgG	Patient 1	22	moderate	G25473LQ	26
IgG	Patient 1	6	moderate	G25473LQ	25
IgM	Patient 1	10	moderate	G25473LQ	44
IgM	Patient 1	22	moderate	G25473LQ	65
IgM	Patient 1	6	moderate	G25473LQ	36
IgA	Patient 2	15	mild	G25473LQ	400
IgA	Patient 2	24	mild	G25473LQ	507
IgG	Patient 2	15	mild	G25473LQ	39
IgG	Patient 2	24	mild	G25473LQ	41
IgM	Patient 2	15	mild	G25473LQ	170
IgM	Patient 2	24	mild	G25473LQ	231